Inventor
RUXER JEAN-MARIE
FR24 patents
⚠️ This page may combine multiple inventors who share the name “RUXER JEAN-MARIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOECHST AG
6 patentsUS5990145ANov 23, 1999
Vitronectin receptor antagonists, their preparation and their use
HOECHST AG21 citations83
US6011045AJan 4, 2000
Vitronectin receptor antagonists, their preparation and their use
HOECHST AG15 citations82
US6482821B2Nov 19, 2002
Vitronectin receptor antagonists, their preparation and their use
HOECHST AG8 citations73
US6218387B1Apr 17, 2001
Vitronectin receptor anatagonists, their preparation and their use
HOECHST AG10 citations73
US6867208B2Mar 15, 2005
Vitronectin receptor antagonists, their preparation and their use
HOECHST AG1 citations63
US6387895B1May 14, 2002
Vitronectin receptor antagonists, their preparation and their use
HOECHST AG4 citations63
AVENTIS PHARMA SA
5 patentsUS7674795B2Mar 9, 2010
Fluorene derivatives, composition containing said derivatives and the use thereof
AVENTIS PHARMA SA38 citations89
US6838453B2Jan 4, 2005
Antagonist derivatives of the vitronectin receptor
AVENTIS PHARMA SA12 citations82
US7550453B2Jun 23, 2009
2-alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
AVENTIS PHARMA SA2 citations62
US6602878B1Aug 5, 2003
Acylquanidine derivatives, method for preparing same, application as medicines and pharmaceutical compositions containing them
AVENTIS PHARMA SA7 citations62
US6391904B1May 21, 2002
Iminoguanidine derivatives, preparation method, use as medicines
AVENTIS PHARMA SA0 citations41
AVENTIS PHARMA GMBH
3 patentsUS6747016B1Jun 8, 2004
Substituted purine derivatives as inhibitors of cell adhesion
AVENTIS PHARMA GMBH14 citations84
US6743800B1Jun 1, 2004
Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
AVENTIS PHARMA GMBH18 citations81
US6867213B2Mar 15, 2005
(2S)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrhydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use
AVENTIS PHARMA GMBH0 citations49
GALAPAGOS SAS
2 patentsUS7582640B2Sep 1, 2009
Vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same
GALAPAGOS SAS12 citations82
US7763621B2Jul 27, 2010
Vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same
GALAPAGOS SAS1 citations51